Dynavax Technologies
DVAX
#4940
Rank
โ‚ฌ1.52 B
Marketcap
12,99ย โ‚ฌ
Share price
0.00%
Change (1 day)
4.30%
Change (1 year)

Revenue for Dynavax Technologies (DVAX)

Revenue in 2025 (TTM): โ‚ฌ0.29 Billion

According to Dynavax Technologies 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.27 Billion. In 2024 the company made a revenue of โ‚ฌ0.26 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ0.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Dynavax Technologies from 2004 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.29 B10.36%
2024 โ‚ฌ0.26 B26.79%
2023 โ‚ฌ0.21 B-68.81%
2022 โ‚ฌ0.67 B73.63%
2021 โ‚ฌ0.38 B925.26%
2020 โ‚ฌ37.84 M20.38%
2019 โ‚ฌ31.43 M338.72%
2018 โ‚ฌ7.16 M2529.45%
2017 โ‚ฌ0.27 M-97.4%
2016 โ‚ฌ10.49 M240.93%
2015 โ‚ฌ3.07 M-55.12%
2014 โ‚ฌ6.86 M-15.79%
2013 โ‚ฌ8.14 M10.94%
2012 โ‚ฌ7.34 M-55.88%
2011 โ‚ฌ16.64 M-7.57%
2010 โ‚ฌ18 M-36.02%
2009 โ‚ฌ28.14 M6.06%
2008 โ‚ฌ26.53 M174.9%
2007 โ‚ฌ9.65 M162.76%
2006 โ‚ฌ3.67 M-70.31%
2005 โ‚ฌ12.37 M13.3%
2004 โ‚ฌ10.91 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚ฌ52.67 B 18,896.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ30.17 B 10,783.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ8.44 B 2,945.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ24.40 B 8,700.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ53.88 B 19,334.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ48.76 B 17,486.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ35.52 B 12,714.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
โ‚ฌ89.61 M-67.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.07 B 4,975.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel